JP2010514421A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514421A5
JP2010514421A5 JP2009543253A JP2009543253A JP2010514421A5 JP 2010514421 A5 JP2010514421 A5 JP 2010514421A5 JP 2009543253 A JP2009543253 A JP 2009543253A JP 2009543253 A JP2009543253 A JP 2009543253A JP 2010514421 A5 JP2010514421 A5 JP 2010514421A5
Authority
JP
Japan
Prior art keywords
vegf
animal
hum
nucleic acid
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009543253A
Other languages
English (en)
Japanese (ja)
Other versions
JP5389665B2 (ja
JP2010514421A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/088537 external-priority patent/WO2008080052A1/en
Publication of JP2010514421A publication Critical patent/JP2010514421A/ja
Publication of JP2010514421A5 publication Critical patent/JP2010514421A5/ja
Application granted granted Critical
Publication of JP5389665B2 publication Critical patent/JP5389665B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009543253A 2006-12-22 2007-12-21 ヒト化ｖｅｇｆを発現するトランスジェニックマウス Expired - Fee Related JP5389665B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87173606P 2006-12-22 2006-12-22
US60/871,736 2006-12-22
PCT/US2007/088537 WO2008080052A1 (en) 2006-12-22 2007-12-21 Transgenic mice expressing humanized vegf

Publications (3)

Publication Number Publication Date
JP2010514421A JP2010514421A (ja) 2010-05-06
JP2010514421A5 true JP2010514421A5 (enExample) 2011-08-18
JP5389665B2 JP5389665B2 (ja) 2014-01-15

Family

ID=39367511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009543253A Expired - Fee Related JP5389665B2 (ja) 2006-12-22 2007-12-21 ヒト化ｖｅｇｆを発現するトランスジェニックマウス

Country Status (5)

Country Link
US (1) US8110720B2 (enExample)
EP (1) EP2099920B1 (enExample)
JP (1) JP5389665B2 (enExample)
ES (1) ES2497496T3 (enExample)
WO (1) WO2008080052A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765093B2 (en) 2010-11-27 2020-09-08 James Zhu Humanized transgenic animal
EP2922393B2 (en) * 2013-02-27 2022-12-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Gene editing in the oocyte by cas9 nucleases
US20140273031A1 (en) * 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
ES2877275T3 (es) 2014-05-30 2021-11-16 Regeneron Pharma Animales con dipeptidil peptidasa IV (DPP4) humanizada
JP2019506897A (ja) * 2016-01-19 2019-03-14 セルジーン コーポレイション ヒトのセレブロンを発現するトランスジェニックマウス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US6130071A (en) * 1997-02-05 2000-10-10 Helsinki University Licensing, Ltd. Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
US6479729B1 (en) * 1998-02-06 2002-11-12 The Johns Hopkins University Mouse model for ocular neovascularization
US20070184023A1 (en) * 2003-10-30 2007-08-09 Pharmexa A/S Method for down-regulation of vegf

Similar Documents

Publication Publication Date Title
JP2019047818A5 (enExample)
CN105582014B (zh) 用于治疗白血病的组合物和方法
NZ591137A (en) Methods and systems for predicting response of cells to a therapeutic agent
RU2016143376A (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
JP2010514421A5 (enExample)
SG178567A1 (en) Affinity-matured humanized anti cea monoclonal antibodies
CN118853594A (zh) 嵌合痘病毒组合物及其用途
JP2014517025A5 (enExample)
WO2010093872A3 (en) Molecular-based method of cancer diagnosis and prognosis
UA114108C2 (uk) Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
Chang et al. Effects of bicarbonate stress on serum ions and gill transporters in alkali and freshwater forms of Amur ide (Leuciscus waleckii)
JP2009523739A5 (enExample)
WO2017117344A1 (en) Fly avatars for cancer and uses thereof
EP3664814A1 (en) Rna aptamers against transferrin receptor (tfr)
JP2010162035A5 (enExample)
JP2012524248A5 (enExample)
CN102492686B (zh) Kctd10基因剔除小鼠模型、构建方法及其应用
EP2576816A4 (en) METHOD AND KIT FOR THE DISTINCTION BETWEEN BREAST CANCER AND A GOOD BREAST DISEASE
JP2008212081A (ja) 肺癌モデル動物およびその利用
CN106319043B (zh) 长链非编码rna linc01420的应用方法
ES2940360T3 (es) Polipéptidos capaces de inhibir la unión entre leptina y neuropilina-1
NZ609198A (en) Her2 dna vaccine as adjunct treatment for cancers in companion animals
KR20160089780A (ko) Dna 결합 단백질을 이용한 나노입자 클러스터 제작방법
KR101734652B1 (ko) 독소루비신 내성 관련 유전자 및 이의 용도
JP5099856B2 (ja) 代謝症候群の治療もしくは予防剤、検査方法、検査薬、及び代謝症候群の治療薬の候補化合物のスクリーニング方法